Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Bayer announces formulation of antibacterial agents

May 31, 1996

Clinical data from Lidakol phase III studies

May 24, 1996

Preliminary phase II results for HNK20

May 24, 1996

RSV inhibitors presented by Wyeth-Ayerst

May 24, 1996

Antiinfluenza activity of LY-180299 described at congress

May 24, 1996

BW-1263W94 selected for clinical testing in CMV infection

May 24, 1996

NF-1153 demonstrates potent activity against influenza virus

May 24, 1996

Japanese researchers present anti-RSV agent at congress

May 24, 1996

NF-1062 evaluated for activity against rotavirus

May 24, 1996

Schering-Plough claims antiherpesvirus agents

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.